Glycosylation of human cyclooxygenase-2 (COX-2) decreases the efficacy of certain COX-2 inhibitors
Authors:
- Mary B. SevignyMSMary B. Sevigny
- Kamara GrahamKGKamara Graham
- Esmeralda PonceEPEsmeralda Ponce
- Maggie C. LouieMLMaggie C. Louie
- Kylie MitchellKMKylie Mitchell
- 1 April 2012
- journal article
- Published by Elsevier in Pharmacological Research
- Vol. 65 (4) , 445-450
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Glycosylation regulates turnover of cyclooxygenase-2FEBS Letters, 2006
- Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trialsBMJ, 2006
- Risk of cardiovascular events and celecoxib: a systematic review and meta-analysisJournal of the Royal Society of Medicine, 2006
- Cyclooxygenase-2—10 Years LaterThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Distinct roles of prostaglandin H synthases 1 and 2 in T-cell developmentJournal of Clinical Investigation, 1999
- Multiple Female Reproductive Failures in Cyclooxygenase 2–Deficient MiceCell, 1997
- Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agentsNature, 1996
- Localization of prostaglandin H synthase type 2 protein and mRNA in term human fetal membranes and deciduaJournal of Endocrinology, 1996
- Higher oxidation states of prostaglandin H synthaseEuropean Journal of Biochemistry, 1988
- Mechanism of enhanced fibroblast arachidonic acid metabolism by mononuclear cell factor.Journal of Clinical Investigation, 1984